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Oreocnide integrifolia (OI) leaves are used as folklore medicine by the people of northeast India to alleviate diabetic symptoms.
Preliminary studies revealed hypoglycemic and hypolipidemic potentials of the aqueous leaf extract. The present study was carried
out to evaluate whether the OI extract induces insulin secretion in vivo and in vitro and also whether it is mediated through the
insulin-signaling pathway. The experimental set-up consisted of three groups of C57BL/6J mice strain: (i) control animals fed with
standard laboratory diet, (ii) diabetic animals fed with a high-fat diet for 24 weeks and (iii) extract-supplemented animals fed with
3% OI extract along with high-fat diet for 24 weeks. OI-extract supplementation lowered adiposity and plasma glucose and insulin
levels.ImmunoblotanalysisofIRS-1,AktandGlut-4proteinexpressionsinmusclesofextract-supplementedanimalsrevealedthat
glucoregulation was mediated through the insulin-signaling pathway. Moreover, immunostaining of pancreas revealed increased
insulin immunopositive cells in OI-extract-treated animals. In addition, the insulin secretogogue ability of the OI extract was
demonstrated when challenged with high glucose concentration using isolated pancreatic islets in vitro.O v e r a l l ,t h ep r e s e n ts t u d y
demonstrates the possible mechanism of glucoregulation of OI extract suggestive of its therapeutic potential for the management
of diabetes mellitus.
1.Introduction
India has recorded the greatest increase of diabetic patients
in recent times and, with a current prevalence of 2.4% in
the rural population and 11.6% in the urban population,
it is estimated that by 2025 India will have the maximum
number of diabetic patients [1, 2]. Although many drugs are
commerciallyavailablefortreatingthedisease,manyofthem
areoutofreachforasigniﬁcantproportionofthepopulation
and are also beset with some adverse eﬀects [3]. Treatments
are essentially aimed at controlling hyperglycemia, which
includes insulin (sulphonylureas, meglitinides, glucagon-like
peptide (GLP) analogs, etc.) and insulin sensitizers which
reduce hepatic glucose generation (metformin) or enhance
peripheral glucose uptake by muscle and adipose tissue
(metformin, thiazolidinediones, etc.), but no drug in vogue
intrinsically exerts both the eﬀects [4]. The use of medicinal
herbs in this context is a meaningful alternative and in
recognitionthisfact,theWorldHealthOrganization(WHO)
has encouraged research in this direction and aﬃrmed
that traditional plant-based treatments for diabetes warrant
further attention [5].
Oreocnide integrifolia (OI; Gaud.) Miq (family:
Urticaceae) are shrubs/small trees mainly distributed
across India, China, Bhutan, Indonesia, Laos, Myanmar,
Sikkim and Thailand [6]. The roots of the OI plant are
mixed with ginger powder and applied for treatment of
rashes by the Khasi and Jayantia tribes of Meghalaya [7, 8].
They are also cooked and eaten for maintaining normal
blood pressure levels by people of Manipur and an infusion
prepared from the leaves is used as a decoction to alleviate
diabetic symptoms [9, 10].
Type 2 diabetes mellitus is a metabolic disease with a
plethora of heterogeneous interrelated manifestations and
complications such as hyperglycemia, hyperinsulinemia,
insulin resistance, impaired glucose tolerance and peripheral
utilization, decreased hepatic glycolysis, increased gluconeo-
genesis, dyslipidemia, and so forth, all of which are related
primarily to insulin and its action. Chronic hyperglycemia
caused due to abnormalities in glucose metabolism and2 Evidence-Based Complementary and Alternative Medicine
insulin resistance characterizes type 2 diabetes mellitus
[11]. Liver being the prime center of glucose homeostasis,
accumulation of hepatic lipids could contribute to insulin
resistance [12]. Increased hepatic free fatty acid production
and elevated plasma levels are characteristic of diabetic
subjects. The higher serum free fatty acids levels lower the
ability of insulin to suppress hepatic glucose production by
activating gluconeogenesis and inhibiting glycolysis [13, 14].
Allthesemetabolicalterationsassociatedwithtype2diabetes
result from a relative insuﬃciency of insulin to overcome
peripheral insulin resistance. Diﬀerent health problems such
as hyperlipidemia, atherosclerosis and hypertension linked
to impaired carbohydrate and lipid metabolisms are all
consequences of both insulin deﬁciency and resistance [15,
16]. Any antidiabetic agent should exert ameliorative eﬀect
onthediabeticmanifestationsbyenhancinginsulinsecretion
and/or by improving/mimicking insulin action. Despite
the existing treatment modalities, there is need for new
treatment paradigms for type 2 diabetes mellitus to control
the progressive metabolic deterioration [17]. Alternative
agents being explored should be able to target the sites of
basic defects ascribed to the disease, which is essentially
islet dysfunction in association with insulin resistance.
Molecular mechanisms underlying these basic defects also
need to be evaluated to have a better understanding. To
facilitate such evaluations, an appropriate clinically relevant
experimental model is required. The C57BL/6J mice when
fed with a high-fat diet develops all classical type 2 diabetic
symptoms such as insulin resistance and insuﬃcient islet
compensation, and hence serves as the ideal model for
studying pathophysiology of impaired glucose tolerance and
type 2 diabetic manifestations at the molecular level [18–
22]. This mouse also serves as a good model for evaluating
the eﬃcacy of new antidiabetic agents as well [23–25].
Natural products from medicinal plants are of focal interest
in the discovery of new chemical entities in modern drug-
discovery programs. It is in this context that we had initiated
studies on OI (Gaud.) Miq used by people in northeastern
part of India. Previously, we had demonstrated potent
antihyperglycemic and antihyperlipidemic eﬀects of OI leaf
extract in streptozotocin-induced diabetic rats [10].
Thus, the present study was planned to evaluate whether
(i) the OI extract brings about insulin secretion in vivo and
in vitro and (ii) whether it is mediated through the insulin-
signaling pathway.
2. Methods
2.1. Plant Extract Preparation. Fresh green leaves were
collected from Imphal district (Manipur) and authenticated
by the botanist, Dr Hemchand Singh, D.M. College of
Science, Manipur University. A voucher specimen (#344)
of the herbarium has been deposited at the department
for future reference. The leaves were collected during the
months of September and October, washed thoroughly and
shade dried at room temperature. The dried leaves were
subjected to size reduction into a coarse powder by using
dry grinder and passed through a (#400) sieve. Two hundred
g r a m so ft h i sp o w d e rw a sm i x e dw i t h1lo fM i l l iQw a t e r
(Millipore, USA) and boiled for 30min and left to cool
down to room temperature. The decoction was ﬁltered
(Whatmann #01) using a suction apparatus and the ﬁltrate
was lyophilized (Buchi, Germany) and kept in freezer at
−20◦C .T h ee x t r a c t i v ev a l u eo ft h ea q u e o u se x t r a c ti nt e r m s
of yield was ∼16.9% (w/w).
2.2. Animals and Diets. Male C57BL/6J mice (age range:
4-5 weeks) were purchased from the National Centre for
Laboratory Animal Service, National Institute of Nutrition,
Hyderabad, India. To make a fully developed insulin-
resistant diet-induced obese (DIO) animal phenotype, 20
animals were fed with a high-fat diet (60kcal% fat, D12492
Research Diet, New Brunswick, NJ, USA); 20 with high-fat
dietsupplemented(mixedwithfeed)with3%OIextractand
20 on the standard laboratory diet for 24 weeks. (BALB)/c
mice (age range: 5-6 months) were used for islet culture
and insulin-secretion assays. The experiment was carried out
accordingtotheguidelinesoftheCommitteeforthePurpose
of Control and Supervision of Experiments on Animals,
India and approved by the Animal Ethical Committee of
Department of Zoology, The M. S. University of Baroda,
Vadodara (Approval No. 827/ac/04/ CPCSEA).
2.2.1. Metabolic Parameters. Body weight and food intake
were recorded during the study period. At the end of the
speciﬁed 24 weeks, animals were sacriﬁced, photographed
for morphology of visceral adipose while muscle and pan-
creas were extracted for evaluation of other parameters.
Hematoxylin-eosin staining was performed in paraﬃns e c -
tions for histological analysis of adipose tissue.
2.2.2. Plasma Glucose and Insulin. Plasma glucose was
measured by the tail-snipping method using One Touch
Glucometer (Elegance, USA). Plasma Insulin was quantiﬁed
according to manufacturer’s protocol using Mouse Insulin
ELISA kit (Mercodia Diagnostics, Uppsala, Sweden).
2.2.3. Western Blot: Membrane Preparation. Plasma
membrane and cytosolic fractions were prepared from
skeletal muscles (gastrocnemius) from both control and
test animals as described by Dombrowski et al. [26].
Brieﬂy stated, 100mg of muscle was homogenized in an
ice-cold homogenization buﬀer (1:10 w/v) containing 25
mmolL−1 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES), 20mMβ-glycerophosphate, 2 mmolL−1
ethylenediaminetetraacetic acid (EDTA), 250mmolL−1
sucrose, 3.3mgL−1 leupeptin, 3.3mgL−1 aprotinin,
100mgL−1 trypsin inhibitor, 1mmolL−1 PMSF, pH 7.4
using a polytron-equipped homogenizer at a precise low
setting on ice. The resulting homogenate was centrifuged at
1300 × g for 10min at 4◦C.The supernatant was saved and
pellet was resuspended in homogenization buﬀer and again
spun at 1300 × g for 10min at 4◦C and the supernatant of
this spin was combined with the ﬁrst one and again spun
at 9000 × g for 10min at 4◦C.The resulting supernatant
was further centrifuged at 190000 × g for 1h (PreparativeEvidence-Based Complementary and Alternative Medicine 3
Ultracentrifuge, Hitachi, Japan). The pellets obtained were
resuspended in homogenization buﬀer and applied on
sucrose gradients (25, 32 and 35% w/w) and centrifuged
at 150000 × g for 16h. Fractions at 25–32 and 32–35%
interfaces were used as plasma membrane and cytosolic
fractions, respectively. Protein concentration was further
determined by the method of Lowry et al. [27].
2.2.4. Separation of Proteins. Brieﬂy, each sample (25μg)
was subjected to heat denaturation at 96◦Cf o r5m i nw i t h
Laemmli buﬀer. The proteins were resolved by sodium dode-
cyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE)
on 10% polyacrylamide gels as described by Laemmli [28]
and then electrophoretically transferred to polyvinylidene
diﬂuoride (PVDF) membrane (Amersham Biosciences, UK).
The membrane was blocked with phosphate-buﬀered saline
plus 0.3% Tween-20 (PBST) containing 10% non-fat dry
milk for 2h and then incubated with anti-GLUT-4 (1:2000;
generous gift from Dr Samuel Cushman, NIDDK, USA),
anti-IRS-1 (1:1000; Cell Signaling, USA), Akt-1 (1:1000;
Cell Signaling, USA) and β-actin (1:2000; Santa Cruz
Biotechnology, USA) primary antibodies overnight. After
three washes with PBST, the membrane was re-blocked and
incubated with secondary antibody (horseradish peroxidase-
conjugateddonkeyanti-rabbitIgG;1:5000;Sigma,St.Louis,
MO, USA) for 2h at room temperature. The blots were
then rinsed in Tris-buﬀered saline with 0.05% Tween 20
and immunoreactive bands were detected by the Enhanced
Chemiluminescence Reagents (ECL; Amersham Biosciences,
UK). Images were captured with a ChemiDoc XRS system
(Bio-Rad Laboratories, CA, USA). Later, the membranes
were incubated in stripping buﬀer (50mL containing
62.5mmolL−1 Tris-HCl (pH: 6.8), 1g SDS and 0.34mL
β-mercaptoethanol) at 55◦C for 40min. After this, the
membrane was reprobed using a β-actin antibody (1:2000).
All protein bands were quantiﬁed using (Image J software,
NIH, USA) and normalized against internal control β-actin.
2.2.5. Immunostaining and Confocal Microscopy. The pan-
creas were aseptically removed from the respective treat-
ment groups and ﬁxed in 4% fresh paraformaldehyde.
The tissues were subsequently embedded in paraﬃnw a x
and sectioned at 5μm thickness with a microtome (Leica,
Wetzlar, Germany) and mounted on poly-l-lysine (Sigma)
coated slides. Slides were de-paraﬃnized, downgraded in
xylene and alcohol and blocked with 4% normal donkey
serum and then incubated with antisera. Guinea pig anti-
insulin antibody (Linco Research Inc, St. Charles, MO,
USA), mouse antiglucagon (Sigma), were used at 1:100
dilutions. Alexa-Fluor 488 and Alexa-Fluor 546 F (ab
 )2
secondary antibodies (Molecular Probes, OR, USA) were
used at 1:200 dilution. Hoechst 33342 was used to visualize
nuclei. Primary antibodies were incubated overnight at 4◦C,
washed with calcium-magnesium-containing PBS and then
incubated with the secondary antibodies at 37◦Cf o r1 h .
Slides were washed extensively in PBS and mounted in
Vectasheild (Vectorlabs). Confocal images were captured
using a Zeiss LSM 510 laser scanning microscope using a
63 × 1.3 oil objective with optical slices ∼0.8 μm. Magniﬁca-
tion, laser and detector gains were set below saturation and
were identical across samples.
2.2.6.IsolationofIslets. Isletisolationwasperformedaccord-
ing to the method of Lacy and Kostianovsky, Shewade et
al. [29, 30]. Groups of three BALB/c mice were killed by
cervicaldislocation,andsplenicpancreaswasremovedunder
sterile conditions without ductal injection and distention.
Brieﬂy, the pancreas was cut into small pieces/chopped
ﬁnely ∼1mm 2 and was subjected to enzymatic digestion for
10–12min by mechanical vigorous shaking in water bath
maintained at 37◦C. The dissociation medium consisted of
Dulbecco’s Modiﬁed Minimum Essential Medium (DMEM)
supplemented with Collagenase type V (1mgmL−1;S i g m a ) ,
and2%BSAfractionV(Sigma).Thetissuedigestedwasthen
centrifuged at 1500×g for 10min, washed twice in PBS (pH:
7.4) and seeded in culture ﬂasks (25cm2; Nunc, Denmark)
containing RPMI-1640 (Hyclone, USA) supplemented with
10%(v/v) FBS (Hi-Media, India), 100UmL−1 penicillin and
100UmL−1 streptomycin under 95% O2 and 5% CO2
atmosphere at 37◦C (Thermo, USA) in air. Under these
culture conditions, most of the acinar cells degenerate within
48h leaving islets. After 48h of incubation, islets were
separated from exocrine pancreas by hand-picking using a
binocularstereomicroscope.TheIsletspeciﬁcitywasassessed
using dithizone (Hi-Media, Mumbai, Maharashtra, India)
and Trypan blue staining was performed for viability.
2.2.7. Insulin Secretion Assay. Isolated islets were cultured at
37◦C in a humidiﬁed atmosphere of 5% CO2 in air in RPMI-
1640 medium containing 11.1 mM glucose, 10% FBS and
antibiotics. Islets were seeded at a concentration of 100 islets
per well in 24-well plates (Falcon, NJ, USA) and allowed to
attach overnight prior to acute tests. Wells were washed 3
times with Krebs-Ringer bicarbonate buﬀer (KRB; 115mM
sodium chloride (NaCl), 4.7mM potassium chloride (KCl);
1.3mM calcium chloride (CaCl2), 1.2mM potassium dihy-
drogen phosphate (KH2PO4), 1.2mM magnesium sulfate
(MgSO4), 24 mM sodium bicarbonate (NaHCO3), 10mM
HEPES, 1gL−1 BSA, 1.1mM glucose; pH: 7.4) and prein-
cubated for 1h at 37◦C. Unless otherwise stated, wells were
then incubated for 1h with 1mL KRB at 4.5mM and 16.7
mM glucose, and OI extract (10, 50, 100 and 250μgmL −1).
Aliquots were removed from each well, centrifuged (1500×g
for 5min, at 4◦C), and assayed for insulin using mouse
insulinELISAkitandproteinconcentrationwasdetermined.
2.3. Statistical Analysis. Statistical evaluation of the data was
done by one-way Analysis of Variance (ANOVA) followed
by Bonferroni Multiple comparison test. The results are
expressedasmean ±SEMusingGraphPadPrismversion3.0
for Windows (Graph Pad Software, San Diego, CA, USA).
3. Results
3.1. Metabolic Parameters. The body weight of diabetic
animals increased signiﬁcantly up to 24 weeks on high-fat4 Evidence-Based Complementary and Alternative Medicine
Control Diabetic OI treated
Figure 1: Control, diabetic and OI extract-treated mice opened to expose the viscera to show the variation in visceral adiposity.
(a) (b) (c)
Figure 2: Histomicrograph of sections of adipose tissue from control (a), diabetic (b) and OI extract-treated (c) mice to depict diﬀerence in
adipocyte dimensions. Scale bar represents 100μm. Magniﬁcation 450×.
diet by 43% as compared to the control mice. Simultaneous
supplementation with OI extract reduced bodyweight gain
to only about 13% which was conﬁrmable by morphological
observation of decreased visceral adiposity (Figure 1). His-
tological analysis of epididymal fat pads revealed increased
adipocyte diameter in diabetic mice which was eﬀectively
checked by OI extract supplementation (Figure 2). Food
consumptiondecreasedsigniﬁcantlyby28%indiabeticmice
as compared to controls whereas OI extract fed diabetic mice
did not show any signiﬁcant change (Table 1).
3.2. Plasma Glucose Levels and Insulin Titer. Plasma blood
glucoselevelwasincreasedby64%inhigh-fatdietmicecom-
paredtocontrols(5.70 ±0.71versus16.12 ±0.81mmolL−1)
at the end of 24 weeks (Table 2). OI extract supplementation
along with high-fat diet resulted in only 20% increase in
plasma glucose levels. The plasma insulin titer decreased in
high-fat diet-fed diabetic mice, while simultaneous supple-
mentation with OI extract showed a non-signiﬁcant change.
3.2.1. Glucose-Induced Insulin Secretion. Islets isolated from
BALB/c mice were incubated with various concentrations
(10, 50, 100 and 250μgmL −1) of OI extract along with basal
(4.5mM) and stimulated (16.7mM) glucose concentrations
(Table 3). There was a dose-dependent eﬀect with 100 and
250μgmL −1 showing maximal insulin secretion at the end
of 60min of incubation.
3.2.2. Western Blot Analysis. Immunoblot analysis was car-
ried out in control, diabetic and OI extract-fed groups
wherein protein-expression pattern of molecules involved
in the insulin-signaling pathway was evaluated in the gas-
trocnemius muscle. IRS-1 expression in muscle (cytosolic
fraction) was decreased signiﬁcantly (P < .01) in diabetic
micecomparedwithcontrolswhileOIextract-supplemented
animals depicted higher near-normal level when compared
withdiabeticanimals(Figure 3).However,AKT-1expression
(cytosolic fraction) of control, diabetic or OI-treated group
did not show any signiﬁcant diﬀerence (Figure 4). Eﬀect
on Glut-4 distribution was evaluated in both cytosolic and
plasma membrane fractions (Figures 5 and 6). Cytosolic
fraction showed no signiﬁcant changes in Glut-4 protein
expression in either control or experimental groups of ani-
mals. However, membrane glut-4 expression was remarkably
reduced (P < .001) in diabetic animals and there was
a conspicuous maintenance of Glut-4 expression in OI-
supplemented group although still lesser than in control
animals.
3.2.3. Insulin/Glucagon Immunostaining of Pancreas. Pan-
creas from diﬀerent groups of animals were immunostained
for insulin at the end of the experimental period (Figure 7).
Diabetic mice showed weak staining for insulin while the
OI extract-supplemented group showed remarkable insulinEvidence-Based Complementary and Alternative Medicine 5
Table 1: Body weight and food intake.
Control Diabetic OI extract treated
Body weight initial (g) 24.2 ± 0.23 23.7 ± 0.41ns 22.6 ± 0.78ns/ns
Body weight ﬁnal (g) 26.1 ± 0.43 41.3 ± 1.81∗∗∗ 29.3 ± 0.48ns/
Weight gain (g) 1.9 ± 0.37 17.6 ± 0.67∗∗∗ 6.7 ± 0.32∗∗∗/
Food intake (g day−1 per mouse) 2.6 ± 0.17 1.87 ± 0.13∗ 2.2 ± 0.18ns/ns
Eﬀect of OI extract on body weight and food intake in control and experimental animals. Mean ± SEM of six animals.
∗∗∗/ P < .001, ∗P < .05, ns = P > .05; where ∗ = control versus diabetic, control versus OI extract-treated and = diabetic versus OI extract-treated.
Table 2: Glucose and insulin.
Control Diabetic OI extract-treated
Glucose (mmol L−1)5 . 7 0 ± 0.71 16.12 ± 0.81∗∗∗ 8.90 ± 0.56∗/
Insulin (pmol L−1) 88.32 ± 7.27 66.39 ± 6.63∗/ns 72.43 ± 10.25ns/ns
Eﬀect of OI extract on plasma levels of glucose and insulin in control and experimental animals. Mean ± SEM of six animals.
∗∗∗/ P < .001, ∗P < .05, ns = P > .05; where ∗ = control versus diabetic, control versus OI extract-treated and = diabetic versus OI extract-treated.
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Figure 3: IRS-1 protein expression in skeletal muscles of control
and experimental animals. Mean ± SEM of six animals. ∗∗∗P <
.001, ∗P < .05; where ∗ = control versus diabetic, control versus OI
extract-treated.
immunopositivity closest to the control islet response. How-
ever, there was no signiﬁcant change in glucagon-positive
cells in control and experimental groups.
4. Discussion
The high-fat diet-fed C57BL/6J mouse is an ideal model for
studying mechanisms of impaired glucose tolerance along
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Figure 4: Akt-1 protein expression in skeletal muscles of control
and experimental animals. Mean ± SEM of six animals ns = P > .05.
with insulin resistance leading to type 2 diabetes marked by
islet dysfunction and for developing novel therapeutic inter-
ventions [31]. The study has tried to evaluate the inﬂuence
of OI extract on glucose-uptake mechanisms in the muscle
of diabetic and non-diabetic C57BL/6J mouse and also the
eﬃcacy of extract in inducing insulin secretion from isolated
islets from BALB/c mice. The C57BL/6J mouse developed
type 2 diabetic manifestation when fed continuously for 24
weeks with a high-fat diet. Diabetic induction was marked
by loss of insulin-positive cells in islets, >200% decrease
in fasting plasma glucose and >20% decrease in plasma6 Evidence-Based Complementary and Alternative Medicine
Table 3: Glucose-induced insulin secretion.
4.5mM Glucose 16.7mM Glucose
pmol l−1 per 100 islets pmol l−1 per 100 islets
Control 50.0 ± 1.66 87.5 ± 3.31
10 μgmL −1 OI extract 47.7 ± 1.94 101.3 ± 1.31∗∗
50 μgmL −1 OI extract 61.3 ± 2.15∗ 112.4 ± 1.80∗∗
100 μgmL −1 OI extract 68.4 ± 1.52∗∗ 125.6 ± 1.30∗∗
250 μgmL −1 OI extract 67.0 ± 2.10∗ 142.9 ± 0.83∗∗
Eﬀect of OI extract on basal and stimulated levels of glucose induced insulin secretion. Mean ± SEM of six animals.
∗∗ P < .01, ∗P < .05; where ∗ = control versus diabetic, control versus OI extract-treated. Mean ± SEM of ﬁve independent experiments. ∗P < .01 when
compared to respective controls and ∗∗P < .01 when compared to respective controls.
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Figure 5: Glut-4 cytosolic protein expression in skeletal muscles of
control and experimental animals. Mean ± SEM of six animals ns =
P > .05.
insulin level accompanied by decreased expressions of IRS-
1 and membrane Glut-4 in the muscle. Supplementation
with OI extract is able to ameliorate the diabetic manifes-
tations marked by noticeable insulin immunoreactivity in
the islets and improved plasma insulin titer and glycemic
level suggesting, both an insulinogenic action as well as
insulin sensitivity-potentiating eﬀect of the OI extract. In
recent times, herbal extracts and compounds isolated from
plants have been shown to have various eﬀects on pancreas,
such as β-cell proliferation, insulin synthesis and secretion,
suggestingthepotentialroleofmedicinalherbsincombating
insulin resistance and insuﬃciency associated with diabetes;
further, Huo et al. [32] showed increased serum insulin
levels on treatment with a powder mixture of eight herbal
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Figure 6: Glut-4 plasma membrane protein expression in skeletal
muscles of control and experimental animals. Mean ± SEM of six
animals. ∗∗∗/P<.001;where ∗ =controlversusdiabetic,control
versusOIextract-treatedand =diabeticv ersusOIe xtract-tr eat ed.
components. Qin et al. [33] showed that Gosha-jinki-gan
(a herbal complex) ameliorates abnormal insulin signaling.
Similarly, Muniappa et al. [34] showed insulin secretogogue
activity and cytoprotective role of Scorparia dulcis (Sweet
Broomweed) and Jayaprakasan et al. [16] demonstrated the
ability of anthocyanins and ursolic acid isolated from the
Cornelian cherry (Cornus mas) for enhanced islet function
and elevated circulating serum insulin levels. Similarly, Leu
et al. [35] have also reported competence of an extract of
Angelica hirsituﬂora to serve as an insulin secretogogue. The
OI extract in our present study seems capable of acting asEvidence-Based Complementary and Alternative Medicine 7
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Figure 7: Guinea pig anti-insulin antibody (Linco Research Inc, MO) and mouse antiglucagon (Sigma) antibodies were used at 1:100
dilutions. Alexa Flour-488 and Alexa Flour 546 F(ab)2 secondary antibodies (Molecular Probes) were used at 1:200 dilution. Hoecsht 33342
was used to visualize nuclei. Confocal images were captured using a Zeiss LSM 510 laser scanning microscope using a ×63/1.3 oil objective
with optical slices ∼0.8μm.
a secretogogue as well, and this is conﬁrmed by the in vitro
ability of the extract to bring about insulin release from
isolated BALB/c mice islets in a dose-dependent manner.
All doses of OI extract-induced 80%–100% proportionate
increase in insulin secretion when the glucose concentration
in the medium was increased from 4.5 to 16.7mM. Taken
with the herein noted eﬀect on pancreatic islets, the current
protective eﬀects seen suggest potential of OI extract to act
at the levels of both insulin production as well as insulin
action. The principal action of insulin on glucoregulation
is through peripheral tissue uptake and metabolism. Muscle
and adipose tissue are the main insulin-sensitive tissues
involved in this process. A defect in insulin receptor or post-
receptor signalling mechanism can have profound eﬀect in
terms of insulin insensitivity. Number of molecular lesions
in muscle and adipose tissue are known to exacerbate
diabetic symptoms and can even be a major cause of
type 2 diabetes [3]. Western blot analysis of some proteins
involved in insulin-induced glucose metabolism in the
muscle tissue in the present study has revealed signiﬁcantly
decreased membrane Glut-4 and cytosolic IRS-1 expressions
in high-fat diet-induced type 2 diabetes. However, Akt-
1 was not signiﬁcantly compromised. Apparently, high-
fat diet-induced type 2 diabetes in C57BL/6J mice has
defective peripheral glucose utilization due to deﬁciency
in IRS-1, resulting in downstream defect in Akt-1-PI-3
kinase activation. This in turn leads to non-phosphorylation
of Glut-4 and its membrane translocation contributing to
reducedglucosetransport[36].Glut-4istheinsulin-sensitive
glucose transporter in skeletal muscle and adipose tissue
and its importance in whole body glucose metabolism has
been elucidated using experimental models of Glut-4 null
mice [37]. Recently, Liu et al. [38] demonstrated the action
of Dang Gui Bu Xue Tang (herbal formulation) on Glut-
4 translocation in fructose-fed rats. Of late, attention has
shifted to herbal extracts/constituents as potential agents for
treatment of type 2 diabetes. Identifying targets of action of
herbal preparations is an essential aspect of therapeutic drug
development in combating molecular lesions characteristic
of insulin resistance and type 2 diabetes. There is, therefore,
a need to evaluate the eﬃcacy of herbal extracts/principles
on a composite scale with regard to molecular defects in
peripheral insulin resistance/glucose utilization. Although
there are a few studies on plant products/principles on
this aspect, their obvious drawbacks lie in the fact that
these studies are either on cultured myoblast cells or on
alloxan/streptozotocin-induced type 1 diabetic animals and
that too restricted to only Glut-4 concentration or glucose
uptake [39–43]. The present study, in this context, has tried
to assess cytosolic and membrane Glut-4, Akt-1 and IRS-1
expressions. The study clearly shows that OI extract is able
to prevent, high-fat diet-induced type 2 diabetic manifes-
tations of under-expression of IRS-1 protein and hampered
membrane translocation of Glut-4 transporter in the skeletal8 Evidence-Based Complementary and Alternative Medicine
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Figure 8: The ﬁgure summaries varied actions of OI extract (dark
dotted arrows with +sign) on Glut-4 translocation from cytosol to
plasma membrane through activation of IRS-1 in skeletal muscles.
In addition, OI extract demonstrated increased glucose-induced
insulin secretion in isolated islets (in vitro) and increased insulin-
immunopositive cells in pancreas (in vivo).
muscle (Figure 8). Overall, the present study eﬀectively
shows that diet-induced type 2 diabetes is characterized by
signiﬁcant islet dysfunction (β-cell loss), with consequent
hypoinsulinemia and peripheral deﬁciency in glucose uptake
by insulin-sensitive peripheral tissues (muscle) and that,
OI extract is adequately competent to counteract these
eﬀects of diet-induced diabetic manifestations. Further, we
have also recorded decreased hepatic 14C glucose oxidation
and increased glucogenesis coupled with gluconeogenesis
as marked by tissue glycogen content and mRNA levels of
glucose-6-phosphatase, glucokinase and phosphoenolpyru-
vate carboxykinase (Ansarullah, Unpublished). Our previ-
ous studies have recorded dose-dependent hypoglycemic
and hypolipidemic eﬀects of OI extract in streptozotocin-
induced diabetic rats [10]. Moreover, preliminary assay of
phytoconstituentspresentinOIextracthasrevealedthepres-
ence of sterols, saponins, terpenoids, ﬂavonoid glycosides
and sugars. (Ansarullah, personal communication). Having
demonstrated the potent eﬀect of OI extract in combating
type 2 diabetic manifestations, our further focus is on
isolation of principles/compounds from the extract to test
the bioactive molecule(s) for development as an alternative
therapeutic agent against type 2 diabetes.
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